Nordson(US:NDSN)2024-12-11 21:36Sales Performance - Fourth quarter sales were $744 million, a 4% increase from $719 million in the prior year[2] - Full year sales reached a record $2.7 billion, reflecting a 2% growth over last year's record sales of $2.628 billion[10] - The Advanced Technology Solutions segment saw a 5% increase in sales to $152 million, driven by a 4% organic sales increase[9] - The Medical and Fluid Solutions segment reported a 19% increase in sales to $200 million, primarily due to the Atrion acquisition[7] - The Industrial Precision Solutions segment experienced a 3% decrease in sales to $392 million, driven by a 5% organic sales decrease[6] - The Industrial Precision Solutions segment reported sales of $1,484,249 thousand for the twelve months ended October 31, 2024, a 6.7% increase from $1,391,046 thousand in 2023[32] - The Medical and Fluid Solutions segment saw a 5.3% increase in sales to $695,452 thousand for the twelve months ended October 31, 2024, compared to $660,316 thousand in the previous year[32] - Total sales for the three months ended October 31, 2024, were $744,482 thousand, representing a 3.5% increase compared to $719,313 thousand for the same period in 2023[32] - The industrial precision solutions segment reported sales of $392,150 thousand for the three months ended October 31, 2024, a decrease of 3.3% from $405,436 thousand in the same period last year[38] - Medical and fluid solutions segment sales increased to $200,223 thousand, up 18.7% from $168,632 thousand in the prior year[38] - Advanced technology solutions segment sales were $152,109 thousand, a 4.0% increase from $145,245 thousand in the same period last year[38] Earnings and Profitability - Adjusted earnings per diluted share for the fourth quarter were $2.78, up from $2.71 in the prior year[3] - Full year adjusted earnings per diluted share were $9.73, compared to $9.85 in the prior year[11] - Operating profit for the three months ended October 31, 2024, was $178,892 thousand, down 3.1% from $185,039 thousand in the prior year[38] - Adjusted net income for the three months ended October 31, 2024, was $160,239 thousand, compared to $156,025 thousand for the same period in 2023, reflecting a 1.4% increase[42] - Diluted earnings per share for the three months ended October 31, 2024, were $2.12, a decrease from $2.22 in the same period last year[42] Cash Flow and Financial Position - Cash flows from operating activities for the twelve months ended October 31, 2024, totaled $556,193 thousand, a decrease of 13.3% from $641,282 thousand in 2023[29] - The company’s cash and cash equivalents at the end of the period were $115,952 thousand, slightly up from $115,679 thousand at the beginning of the period[29] - Free cash flow for the year to date as of October 31, 2024, was $491,783 thousand, compared to $416,026 thousand for the same period in 2023, indicating a 18.1% increase[45] EBITDA and Backlog - EBITDA for the fourth quarter was $241 million, representing 32% of sales, a 4% increase from $227 million in the prior year[4] - EBITDA for the twelve months ended October 31, 2024, was $849,168 thousand, an increase from $818,974 thousand in the previous year, reflecting a growth of 3.7%[35] - EBITDA for the three months ended October 31, 2024, was $241,096 thousand, representing a 6.1% increase from $227,100 thousand in the prior year[38] - The company has approximately $580 million in backlog entering fiscal 2025[14] Assets and Liabilities - The company reported a total current assets increase to $1,275,032 thousand as of October 31, 2024, compared to $1,229,310 thousand in 2023, marking a growth of 3.7%[26] - Long-term debt increased to $2,101,197 thousand as of October 31, 2024, up from $1,621,394 thousand in the previous year, indicating a rise of 29.5%[26] - The company’s total shareholders' equity increased to $2,932,192 thousand as of October 31, 2024, compared to $2,598,060 thousand in 2023, representing a growth of 12.8%[26]